{"database": "lobbying", "table": "lobbying_activities", "rows": [[1162316, "e9f77976-2fa2-4414-8a64-3a1b27304d7b", "Q3", "C2 GROUP, LLC", 66693, "PERRIGO INC", 2011, "third_quarter", "PHA", "OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2011-10-19T19:00:06.377000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1162316"], "units": {}, "query_ms": 0.7997460197657347, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}